358PComplete responses in patients with second-line or greater metastatic triple negative breast cancer (TNBC) following first-in-human immunotherapy combining NK and T cell activation with off-the-shelf high-affinity CD16 NK cell line (haNK)
Nangia, C, Soon-Shiong, P, Rabizadeh, S, Lee, J H, Sender, L, Jones, F, Kistler, M, Niazi, K, Seery, T, Rock, A, Jafari, OVolume:
30
Langue:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz242.053
Date:
October, 2019
Fichier:
PDF, 74 KB
english, 2019
File converter
Plus de résultats de recherche
More benefits 
